Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
- First Posted Date
- 2010-10-19
- Last Posted Date
- 2021-12-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 799
- Registration Number
- NCT01224106
- Locations
- 🇺🇸
Butler Hospital, Providence, Rhode Island, United States
🇧🇷Hospital Mae de Deus, Porto Alegre, RS, Brazil
🇩🇰Rigshospitalet, Hukommelsesklinikken, Koebenhavn Oe, Denmark
An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)
- Conditions
- Lymphocytic Leukemia, Chronic
- Interventions
- Drug: Chemotherapy
- First Posted Date
- 2010-10-19
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 219
- Registration Number
- NCT01224093
An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer
- Conditions
- Gastric Cancer
- First Posted Date
- 2010-10-14
- Last Posted Date
- 2018-06-20
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 443
- Registration Number
- NCT01220934
- Locations
- 🇩🇪
Krankenhaus Nordwest; Klinik f. Onkologie und Hämatologie, Frankfurt, Germany
A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection
- Conditions
- Hepatitis C, Chronic
- Interventions
- First Posted Date
- 2010-10-14
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 421
- Registration Number
- NCT01220947
A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2015-01-19
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 68
- Registration Number
- NCT01219933
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
- First Posted Date
- 2010-10-06
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 28
- Registration Number
- NCT01215123
A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis
- First Posted Date
- 2010-10-05
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 30
- Registration Number
- NCT01214733
A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer
- First Posted Date
- 2010-10-05
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 607
- Registration Number
- NCT01214720
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)
- Conditions
- Anemia
- First Posted Date
- 2010-10-04
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 419
- Registration Number
- NCT01213485
Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)
- First Posted Date
- 2010-09-29
- Last Posted Date
- 2012-11-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 75
- Registration Number
- NCT01211626
- Locations
- 🇳🇱
Erasmus MC (EMC), Rotterdam, Netherlands
🇳🇱Academisch Medisch Centrum (AMC), Amsterdam, Netherlands
🇳🇱PRA Clinical Research Unit, Groningen, Netherlands